Navigation Links
Nektar Therapeutics Reports Fourth Quarter and Year End 2010 Financial Results
Date:3/1/2011

ficer of Nektar.  “Our lead oncology program, NKTR-102, demonstrated positive results in Phase 2 studies in both ovarian and breast cancers, and we plan to move into Phase 3 in 2011.  NKTR-118, partnered with AstraZeneca, and NKTR-061, partnered with Bayer, are both planned to move into Phase 3 this year as well.  Lastly, Nektar’s research pipeline is on track to deliver one new clinical candidate each year, and we are looking forward to starting Phase 1 clinical studies of NKTR-181, our novel opioid analgesic, this month."

Net loss for the fourth quarter ended December 31, 2010 was $22.6 million or $0.24 per share, as compared to a net loss of $7.7 million or $0.08 per share in the fourth quarter of 2009.  The fourth quarter 2010 net loss includes a non-cash impairment charge of $12.6 million, or $0.13 per share, for the write-down related to the move to Nektar’s new San Francisco, California Mission Bay R&D center from its San Carlos facility.  Net loss for the full year 2010 improved to $37.9 million, or $0.40 per share, as compared to a net loss of $102.5 million, or $1.11 per share, in 2009.  

Conference Call to Discuss Fourth Quarter and Year End 2010 Financial ResultsA conference call to review the financial results will be held today, Tuesday, March 1, 2011 at 2 PM Pacific Time/5 PM Eastern time.  

Details are below:

The press release and a live audio-only Webcast of the conference call can be accessed through a link that is posted on the home page and Investor Relations section of the Nektar website: http://www.nektar.com. To access the conference call, follow these instructions:Dial: 1-866-713-8307; 617-597-5307 (international)Passcode: 79375407 (Nektar Therapeutics is the host)An audio replay will also be available shortly following the call through Tuesday, March 29, 2011 and can be accessed by dialing (888) 286-8010 (U.S.); or (61
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Nektar Therapeutics President and CEO Howard W. Robin to Present at the 31st Annual Cowen and Company Healthcare Conference in Boston
2. Nektar to Announce Financial Results for the Fourth Quarter and Year-End of 2010 on Tuesday, March 1, 2011, After Close of U.S.-Based Financial Markets
3. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 29th Annual J.P. Morgan Healthcare Conference in San Francisco, CA
4. Nektar Therapeutics Reports Third Quarter 2010 Financial Results
5. Nektar to Announce Financial Results for the Third Quarter of 2010 on Thursday, November 4, 2010, After Close of U.S.-Based Financial Markets
6. Nektar Presents New Preclinical Data on NKTR-181 at Anesthesiology 2010
7. Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer
8. Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug-Drug Interaction Profile for NKTR-118
9. Nektar Therapeutics Reports Second Quarter 2009 Financial Results
10. Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)
11. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... , May 24, 2013 In accordance with ... and Rule 14e-1 of the United States Exchange Act, Echo ... original offer for Elan Corporation (NYSE: ELN). Background ... ("Royalty Pharma") made an offer for the entire of the ... plc ("Elan") (the "Original Offer").  On 20 ...
(Date:5/24/2013)... The potential of the pulmonary route as ... has been receiving undeniable attention with the recent advances ... crucial formulation considerations for orally inhaled products together with ... in the efficiency of pulmonary delivery, and great strides ... techniques and devices in recent years. With ...
(Date:5/23/2013)... SHENYANG, CHINA , May 24, 2013 /PRNewswire/ ... ("3SBio" or the "Company"), a leading ... developing, manufacturing and marketing biopharmaceutical products, announced today ... (the "EGM"), the Company,s shareholders voted in favor ... previously announced agreement and plan of merger dated ...
Breaking Medicine Technology:Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 2Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 3Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 4Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 5Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 6Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 7Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 8Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 9Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3
... 2011 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (NASDAQ: SSRX ... company focused on researching, developing, manufacturing and marketing biopharmaceutical ... second quarter 2011 results after the NASDAQ stock market ... Eastern). Following the earnings announcement, 3SBio,s ...
... RIVER EDGE, N.J., July 21, 2011 Nephros, Inc. ... device company developing and marketing filtration products for therapeutic ... the Company has received 510k clearance from the U.S. ... SSU ultrafilters to filter out biological contaminants from water ...
Cached Medicine Technology:3SBio Inc. Schedules Unaudited Second Quarter 2011 Results 2Nephros Receives 510k Approval to Market Additional Ultrafiltration Products 2Nephros Receives 510k Approval to Market Additional Ultrafiltration Products 3Nephros Receives 510k Approval to Market Additional Ultrafiltration Products 4
(Date:5/25/2013)... (PRWEB) May 25, 2013 Today, Zane ... insurance marketplaces . Zane Benefits, which provides comprehensive and ... the leader in defined contribution plans and ... the October 1, 2013 open enrollment of the Health ... of the Marketplaces is "Choice, Competition and Clout for ...
(Date:5/25/2013)... Imagine running the air conditioner with the windows open all ... energy! If the home has a folding pull-down attic stair, ... may be just what is occurring in the home every ... in the form of higher energy bills. Drafts are the ... , Drafts occur through the small cracks around doors, windows, ...
(Date:5/25/2013)... NYC,NY (PRWEB) May 25, 2013 Dr. ... only non-invasive procedure FDA-approved to lift skin on the neck, ... available at her practice, Medical Aesthetics. , Ultherapy is a ... body’s own natural healing process to lift the skin over ... the first time, to see and then treat the deepest ...
(Date:5/25/2013)... Communities of Distinction TV announces May ... largest media market in the United States with almost three ... in Texas and a major convention city. Ft. Worth is ... it is home to many major museums. Both cities offer ... the arts. Residents and locals will be able to watch ...
(Date:5/25/2013)... 25 (HealthDay News) -- Many viruses and parasites that ... leptospirosis -- a bacteria-borne illness than can result in ... dog parks, according to a veterinarian. These ... even the air, said Dr. Susan Nelson, a clinical ... "Many of these serious diseases can be fatal, even ...
Breaking Medicine News(10 mins):Health News:Zane Benefits Publishes New Information on the Health Insurance Marketplaces 2Health News:Zane Benefits Publishes New Information on the Health Insurance Marketplaces 3Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 2Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 3Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 4Health News:Dr. Leslie Gerstman Is Now Offering the Non-surgical Facelifting Procedure – Ultherapy – in NYC and NJ 2Health News:Communities of Distinction TV Presents May Air Dates for Dallas-Ft. Worth, Texas 2Health News:Hidden Dangers Dog Dog Parks 2
... announces the launch of a brand new internet-based ... Fintan Walton, CEO, PharmaVentures, says, ‘This show, the ... the pharmaceutical and biotechnology sectors with insightful analysis ... It gives exclusive access to topical interviews with ...
... are no effective in encouraging students to adopt safe ... has found. The study, conducted by Mexican researchers has ... the transmission of AIDS/HIV and other sexually transmitted infections. ... importance of condom use and refraining from sex (abstinence), ...
... State Auditor Pat Anderson says that the taxpayers are in ... state has not set aside anything in term of their ... challenge that state and local governments are yet to face. ... help pay pension benefits but nothing when it comes to ...
... In a breakthrough and an answer to so many people’s ... eat and overeat. //, ,These scientists studied brain ... brains which tend to be especially sensitive to ads featuring ... areas are greatly stimulated by food images it is likely ...
... Organization (WHO) has praised the way in which the two ... but criticized china.// China threatened the rest of the world ... critical early months. ,In its book WHO talks ... also talks about the way by which Taiwan handled the ...
... affects 300, 000 Americans each year. A problem with such ... time they reach an emergency room.// Among these cases, 10 ... with 64 percent having significant disability. Around 5 percent will ... presented at the 2006 Society for Academic Emergency Medicine Annual ...
Cached Medicine News:Health News:PharmaVentures Exploits Fastest Growing Media Channel to Launch First Pharmaceutical Business Television Show 2Health News:The persistent urge to eat: Loose control!!! 2Health News:Prompt Diagnosis Could Be Life-Saving In Mini-Strokes 2
The Shandon Linistain SLS Linear Stainer is an economical mid-size linear stainer for staining procedures that do not require heat....
... is a manual rotary microtome for routine ... flywheel designed to address repetitive stress injury. ... debris tray, organizer storage tray and a ... standard and may be disengaged at the ...
... remote monitoring service allows the the ... monitored from any location via modem ... enhances preventive maintenance capabilities. Thermo ... unit (with your permission) from their ...
... Tissue Processor is the most ... reagents today. It comes equipped ... to provide benefits of safety, ... reagent cost savings and quality ...
Medicine Products: